CD2; CD3; CD4; CD5; CD7; CD8; CD10; CD16; CD19; CD20; CD22; CD23; CD38; CD45; CD56; CD57; CD79b; CD200; FMC7; Surface Kappa; Surface Lambda
Immunophenotyping by Flow Cytometry is used on fresh tissue biopsies to distinguish lymphomas from reactive lymph nodes and in the sub-classification of non-Hodgkin's lymphomas.
Body fluids can be used to substantiate the diagnosis, direct treatment, and predict outcome based on the cells present in the fluid.
This test is for tissues, lymph nodes, and body fluids ONLY. If peripheral blood or bone marrow see B-Cell CLL/Lymphoma Panel.
Place tissues and lymph nodes in RPMI media as soon as possible after collection.
Body fluids should be collected into sterile collection containers. Deliver entire collection container to the laboratory to be aliquotted by laboratory staff.
A copy of the requisition must accompany the sample to the laboratory and the Flow department.
Tissue biospy or Fine Needle Aspirates must be placed in RPMI media as soon after collection as possible. Contact the Flow Cytometry Department (260-266-1580) for RPMI tubes if needed.
Body Fluids are preferred in their original collection container, especially for CSF. Lavender EDTA tube or Sodium Heparin green top tubes are also acceptable.
CSF collections should be put in the sterile screw top tubes in CSF collection kits. These collection kits contain four tubes with 1-4 printed on the tube. Flow testing will be performed on tube 3 or 4.
All other body fluids should be delivered to the laboratory in their original collection container.
Use a sterile collection container to collect as much fluid as possible.
Laboratory processing staff will aliquot from original collection container to the appropriate sample containers for the testing ordered.
CSF samples should always remain in the CSF Collection tube, do not aliquot.
Samples are considered irretrievable and every attempt will be made to process the sample. The Pathologist will determine if sample should be rejected if unacceptable collection, processing, or handling occurs.
Tissues, Lymph nodes, and Fine Needle Aspirates should be placed in RPMI media as soon after collection as possible. Contact the Flow Cytometry Department (260-266-1580) if RPMI tubes are needed.
Deliver to the lab as soon as possible.
Samples are considered irretrievable and every attempt will be made to process the sample. The Pathologist will determine if sample should be rejected if unacceptable collection, processing, or handling occurs.
Refer to Interpretive Pathology Flow Report.
Immunophenotyping by Flow Cytometry is used on fresh tissue biopsies to distinguish lymphomas from reactive lymph nodes and in the sub-classification of non-Hodgkin's lymphomas.
Body fluids can be used to substantiate the diagnosis, direct treatment, and predict outcome based on the cells present in the fluid.
This test was developed and its performance characteristics determined by Parkview Health Laboratories. It has not been cleared or approved by the FDA. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.
48 to 72 hours
01399703, 01399705
88184, 88185 x19